- Home
- MDXG vs EH Comparison
MDXG vs EH Comparison
Compare MDXG & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDXG | EH |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MDXG | EH |
|---|---|---|
| Price | $6.94 | $14.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $12.00 | ★ $21.85 |
| AVG Volume (30 Days) | 777.2K | ★ 1.1M |
| Earning Date | 10-29-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $393,442,000.00 | $60,400,607.00 |
| Revenue This Year | $19.13 | $13.66 |
| Revenue Next Year | $2.11 | $75.95 |
| P/E Ratio | $25.66 | ★ N/A |
| Revenue Growth | 14.77 | ★ 23.39 |
| 52 Week Low | $5.79 | $12.71 |
| 52 Week High | $10.14 | $29.76 |
Technical Indicators
Market Signals| Indicator | MDXG | EH |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 40.52 |
| Support Level | $6.62 | $13.49 |
| Resistance Level | $6.97 | $14.47 |
| Average True Range (ATR) | 0.26 | 0.56 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 50.63 | 63.57 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.